Suchergebnisse - "Smith, Terry J"

PubPharm (410)

31

Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves' Orbitopathy

enthalten in: European journal of endocrinology | 2021

von Smith, T.

CommentOn: Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. - PMID 34297684

32

3' Tth Endonuclease Cleavage Polymerase Chain Reaction (3TEC-PCR) Technology for Single-Base-Specific Multiplex Pathogen Detection using a Two-Oligonucleotide System

enthalten in: International journal of molecular sciences | 2021

von Higgins, O. | Smith, T.

33

Teprotumumab for patients with active thyroid eye disease : a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials

enthalten in: The lancet. Diabetes & endocrinology | 2021

von Kahaly, G. | Douglas, R. | Holt, R. | +2

CommentIn: Lancet Diabetes Endocrinol. 2021 Jun;9(6):323-325. - PMID 33865499

34

Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy

enthalten in: Cells | 2021

von Janssen, J. | Smith, T.

35

Teprotumumab for Optic Neuropathy in Thyroid Eye Disease

enthalten in: JAMA ophthalmology | 2021

von Slentz, D. | Smith, T. | Kim, D. | +1

36

Insulin-Like Growth Factor Pathway and the Thyroid

enthalten in: Frontiers in endocrinology | 2021

von Smith, T.

37

Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy

Erschienen: 2021

von Fernando, R. | Caldera, O. | Smith, T.

38

Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes : Potential Relevance to Thyroid-Associated Ophthalmopathy

enthalten in: The Journal of clinical endocrinology and metabolism | 2021

von Fernando, R. | Smith, T.

CommentIn: J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1907-e1908. - PMID 33367675

39

Efficacy and Safety of Teprotumumab in Thyroid Eye Disease

enthalten in: Therapeutics and clinical risk management | 2021

von Teo, H. | Smith, T. | Joseph, S.

40

Teprotumumab Treatment for Thyroid-Associated Ophthalmopathy

enthalten in: European thyroid journal | 2020

von Smith, T.